Association of DNA methylation of vitamin D metabolic pathway related genes with colorectal cancer risk

被引:5
作者
Wang, Yi-Fan [1 ]
Li, Lei [1 ]
Deng, Xue-Qing [2 ]
Fang, Yu-Jing [3 ]
Zhang, Cai-Xia [1 ]
机构
[1] Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou 510080, Peoples R China
[2] Sun Yat Sen Univ, Expt Teaching Ctr, Sch Publ Hlth, Guangzhou 510080, Peoples R China
[3] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Canc Ctr ,Dept Expt Res,Collaborat Innovat Ctr Can, 651 Dongfeng Rd East, Guangzhou 510060, Peoples R China
关键词
Vitamin D metabolic pathway related genes; DNA methylation; VDR; Colorectal cancer; EPIGENETIC REGULATION; CYP24A1; EXPRESSION; MUCOSA; MARKER; SYSTEM; CYP2R1; CHINA; SERUM;
D O I
10.1186/s13148-023-01555-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Vitamin D might have anti-tumor effect, which is affected by the genes related to vitamin D metabolic pathway. Epigenetic mechanism may affect the expression level of vitamin D metabolic pathway related genes, then plays an important role in the occurrence and development of colorectal cancer. To date, no study has reported on the association between blood-based DNA methylation level of vitamin D metabolic pathway related genes and colorectal cancer risk. Methods A case-control study was conducted including 102 colorectal cancer cases and 102 sex- and age-frequency-matched controls in Guangzhou, China. CpG islands in the VDR, CYP24A1, CYP27B1 and CYP2R1 genes were chosen for DNA methylation analysis by MethylTarget sequencing. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of DNA methylation levels for colorectal cancer. Taking the point with the largest Youden index as the boundary value, the cumulative methylation levels of vitamin D metabolic pathway related genes were divided into hypomethylation and hypermethylation. Unconditional multivariable logistical regression model was used to calculate the adjusted odds ratio (aOR) and 95% confidence intervals (95% CIs) after adjusting for potential confounders. Results Among 153 CpG sites, 8 CpG sites were significantly different between the cases and the controls. The cumulative methylation level of all CpG sites in CYP2R1 was inversely associated with the risk of colorectal cancer (aOR, 0.49; 95% CI, 0.26-0.91). However, no significant association was found between cumulative methylation levels of all CpG sites in VDR, CYP24A1 and CYP27B1 and colorectal cancer risk. Significant inverse association was observed between cumulative methylation level of significant CpG sites in VDR (aOR, 0.28; 95% CI, 0.16-0.51) and CYP24A1 (aOR, 0.19; 95% CI, 0.09-0.40) and colorectal cancer risk. There were no significant associations between cumulative methylation levels of significant CpG sites in CYP2R1 and CYP27B1 and colorectal cancer risk. Conclusions This study indicated that the cumulative methylation levels of significant CpG sites in VDR and CYP24A1 and all CpG sites in CYP2R1 were inversely associated with colorectal cancer risk.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Antioxidant and DNA methylation-related nutrients and risk of distal colorectal cancer
    Christina Dawn Williams
    Jessie A. Satia
    Linda S. Adair
    June Stevens
    Joseph Galanko
    Temitope O. Keku
    Robert S. Sandler
    Cancer Causes & Control, 2010, 21 : 1171 - 1181
  • [32] Antioxidant and DNA methylation-related nutrients and risk of distal colorectal cancer
    Williams, Christina Dawn
    Satia, Jessie A.
    Adair, Linda S.
    Stevens, June
    Galanko, Joseph
    Keku, Temitope O.
    Sandler, Robert S.
    CANCER CAUSES & CONTROL, 2010, 21 (08) : 1171 - 1181
  • [33] DNA methylation and chromatin modifiers in colorectal cancer
    Vymetalkova, Veronika
    Vodicka, Pavel
    Vodenkova, Sona
    Alonso, Sergio
    Schneider-Stock, Regine
    MOLECULAR ASPECTS OF MEDICINE, 2019, 69 : 73 - 92
  • [34] Contribution of vitamin D and calcium-sensing receptors methylation to the risk of colorectal cancer in Saudi patients
    Fallatah, Meaad I.
    Al-Ghafari, Ayat B.
    Al-Zahrani, Maryam H.
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2022, 13 (12): : 1324 - 1328
  • [35] The Role of Vitamin D Receptor Gene Polymorphisms in Colorectal Cancer Risk
    Messaritakis, Ippokratis
    Koulouridi, Asimina
    Sfakianaki, Maria
    Vogiatzoglou, Konstantinos
    Gouvas, Nikolaos
    Athanasakis, Elias
    Tsiaoussis, John
    Xynos, Evangelos
    Mavroudis, Dimitris
    Tzardi, Maria
    Souglakos, John
    CANCERS, 2020, 12 (06)
  • [36] B-vitamin intake, metabolic genes, and colorectal cancer risk (United States)
    Marchand, LL
    Donlon, T
    Hankin, JH
    Kolonel, LN
    Wilkens, LR
    Seifried, A
    CANCER CAUSES & CONTROL, 2002, 13 (03) : 239 - 248
  • [37] B-vitamin intake, metabolic genes, and colorectal cancer risk (United States)
    Loïc Le Marchand
    Timothy Donlon
    Jean H. Hankin
    Laurence N. Kolonel
    Lynne R. Wilkens
    Ann Seifried
    Cancer Causes & Control, 2002, 13 : 239 - 248
  • [38] DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/β-catenin signaling pathway genes
    Farkas, Sanja A.
    Vymetalkova, Veronika
    Vodickova, Ludmila
    Vodicka, Pavel
    Nilsson, Torbjorn K.
    EPIGENOMICS, 2014, 6 (02) : 179 - 191
  • [39] Genetic polymorphisms of vitamin D metabolism genes and serum level of vitamin D in colorectal cancer
    Vidigal, Veronica Marques
    Nazareth Aguiar Junior, Pedro
    Silva, Tiago Donizetti
    de Oliveira, Juliana
    Marques Pimenta, Celia Aparecida
    Felipe, Aledson Vitor
    Forones, Nora Manoukian
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (04) : E441 - E446
  • [40] Vitamin D Gene Pathway Polymorphisms and Risk of Colorectal, Breast, and Prostate Cancer
    McCullough, Marjorie L.
    Bostick, Roberd M.
    Mayo, Tinisha L.
    ANNUAL REVIEW OF NUTRITION, 2009, 29 : 111 - 132